心的外傷後ストレス障害治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2741)
◆英語タイトル:Global Post-Traumatic Stress Disorder Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2741
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、心的外傷後ストレス障害治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(抗うつ薬、抗不安薬、その他)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・心的外傷後ストレス障害治療の市場動向
・企業の競争状況、市場シェア
・心的外傷後ストレス障害治療の種類別市場規模(抗うつ薬、抗不安薬、その他)
・心的外傷後ストレス障害治療の用途別市場規模(病院、クリニック、その他)
・心的外傷後ストレス障害治療の北米市場規模2016-2027(アメリカ、カナダ)
・心的外傷後ストレス障害治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・心的外傷後ストレス障害治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・心的外傷後ストレス障害治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・心的外傷後ストレス障害治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Pfizer, Inc.、GlaxoSmithKline plc、Otsuka Pharmaceutical Co., Ltd、Novartis AG、AstraZeneca Plc、Azevan Pharmaceuticals, Inc.、Bionomics Ltd.、Tonix Pharmaceuticals Holding Corp.、Apotex, Inc.)
・結論
【レポートの概要】

The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication.

Market Analysis and Insights: Global Post-Traumatic Stress Disorder Treatment Market
The global Post-Traumatic Stress Disorder Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Traumatic Stress Disorder Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Traumatic Stress Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Traumatic Stress Disorder Treatment market.

Global Post-Traumatic Stress Disorder Treatment Scope and Market Size
Post-Traumatic Stress Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antidepressants
Anti-Anxiety Drugs
Others

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer, Inc.
GlaxoSmithKline plc
Otsuka Pharmaceutical Co., Ltd
Novartis AG
AstraZeneca Plc
Azevan Pharmaceuticals, Inc.
Bionomics Ltd.
Tonix Pharmaceuticals Holding Corp.
Apotex, Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antidepressants
1.2.3 Anti-Anxiety Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder Treatment Market Perspective (2016-2027)
2.2 Post-Traumatic Stress Disorder Treatment Growth Trends by Regions
2.2.1 Post-Traumatic Stress Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Post-Traumatic Stress Disorder Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Post-Traumatic Stress Disorder Treatment Industry Dynamic
2.3.1 Post-Traumatic Stress Disorder Treatment Market Trends
2.3.2 Post-Traumatic Stress Disorder Treatment Market Drivers
2.3.3 Post-Traumatic Stress Disorder Treatment Market Challenges
2.3.4 Post-Traumatic Stress Disorder Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder Treatment Players by Revenue (2016-2021)
3.1.2 Global Post-Traumatic Stress Disorder Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Post-Traumatic Stress Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder Treatment Revenue
3.4 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Treatment Revenue in 2020
3.5 Post-Traumatic Stress Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder Treatment Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Post-Traumatic Stress Disorder Treatment Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Type (2016-2021)
4.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Type (2022-2027)

5 Post-Traumatic Stress Disorder Treatment Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder Treatment Historic Market Size by Application (2016-2021)
5.2 Global Post-Traumatic Stress Disorder Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Post-Traumatic Stress Disorder Treatment Market Size (2016-2027)
6.2 North America Post-Traumatic Stress Disorder Treatment Market Size by Type
6.2.1 North America Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2021)
6.2.2 North America Post-Traumatic Stress Disorder Treatment Market Size by Type (2022-2027)
6.2.3 North America Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2027)
6.3 North America Post-Traumatic Stress Disorder Treatment Market Size by Application
6.3.1 North America Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2021)
6.3.2 North America Post-Traumatic Stress Disorder Treatment Market Size by Application (2022-2027)
6.3.3 North America Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2027)
6.4 North America Post-Traumatic Stress Disorder Treatment Market Size by Country
6.4.1 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2016-2021)
6.4.2 North America Post-Traumatic Stress Disorder Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Post-Traumatic Stress Disorder Treatment Market Size (2016-2027)
7.2 Europe Post-Traumatic Stress Disorder Treatment Market Size by Type
7.2.1 Europe Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2021)
7.2.2 Europe Post-Traumatic Stress Disorder Treatment Market Size by Type (2022-2027)
7.2.3 Europe Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2027)
7.3 Europe Post-Traumatic Stress Disorder Treatment Market Size by Application
7.3.1 Europe Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2021)
7.3.2 Europe Post-Traumatic Stress Disorder Treatment Market Size by Application (2022-2027)
7.3.3 Europe Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2027)
7.4 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country
7.4.1 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2016-2021)
7.4.2 Europe Post-Traumatic Stress Disorder Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size (2016-2027)
8.2 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Type
8.2.1 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Application
8.3.1 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region
8.4.1 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Post-Traumatic Stress Disorder Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder Treatment Market Size (2016-2027)
9.2 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Type
9.2.1 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2027)
9.3 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Application
9.3.1 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2027)
9.4 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country
9.4.1 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Post-Traumatic Stress Disorder Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size (2016-2027)
10.2 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Type
10.2.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Application
10.3.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country
10.4.1 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Post-Traumatic Stress Disorder Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.1.5 Pfizer, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Treatment Introduction
11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Otsuka Pharmaceutical Co., Ltd
11.3.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Treatment Introduction
11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Post-Traumatic Stress Disorder Treatment Introduction
11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Details
11.5.2 AstraZeneca Plc Business Overview
11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Treatment Introduction
11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.5.5 AstraZeneca Plc Recent Development
11.6 Azevan Pharmaceuticals, Inc.
11.6.1 Azevan Pharmaceuticals, Inc. Company Details
11.6.2 Azevan Pharmaceuticals, Inc. Business Overview
11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.6.5 Azevan Pharmaceuticals, Inc. Recent Development
11.7 Bionomics Ltd.
11.7.1 Bionomics Ltd. Company Details
11.7.2 Bionomics Ltd. Business Overview
11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Treatment Introduction
11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.7.5 Bionomics Ltd. Recent Development
11.8 Tonix Pharmaceuticals Holding Corp.
11.8.1 Tonix Pharmaceuticals Holding Corp. Company Details
11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview
11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Treatment Introduction
11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Development
11.9 Apotex, Inc.
11.9.1 Apotex, Inc. Company Details
11.9.2 Apotex, Inc. Business Overview
11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Treatment Introduction
11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Treatment Business (2016-2021)
11.9.5 Apotex, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心的外傷後ストレス障害治療の世界市場規模・現状・予測2021年-2027年(Global Post-Traumatic Stress Disorder Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。